Skip to main content

Kenvue Inc.

corporate_fare Company Profile

Kenvue Inc.

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Exchange: NYSESector: Life Sciences

Kenvue Inc. (NYSE:KVUE) is a publicly traded company in the Life Sciences sector. Wiseek monitors KVUE SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Kenvue Confirms Strong Q1 Earnings, Details New Restructuring Plan Amidst Ongoing Legal Challenges
  • Kenvue Halts Forward Guidance Citing Pending Kimberly-Clark Acquisition
  • Kenvue Reports Strong Q1 Results, Exceeding Sales Estimates with Significant EPS and Margin Growth
  • Kenvue Beats Q1 Sales Estimates, Reports $0.32 Adjusted EPS
  • Study Reveals 10-20% Drop in Tylenol Use Among Pregnant Women Post-Trump Autism Claim

show_chartPrice Chart

Loading chart...

feed KVUE - Latest Insights

KVUE
May 07, 2026, 7:50 AM EDT
Filing Type: 10-Q
Importance Score:
7
KVUE
May 07, 2026, 6:35 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
KVUE
May 07, 2026, 6:32 AM EDT
Filing Type: 8-K
Importance Score:
8
KVUE
May 07, 2026, 6:30 AM EDT
Source: Reuters
Importance Score:
8
KVUE
Mar 06, 2026, 12:37 PM EST
Source: Reuters
Importance Score:
7
KVUE
Feb 20, 2026, 7:13 AM EST
Filing Type: 10-K
Importance Score:
8
KVUE
Feb 17, 2026, 4:46 PM EST
Filing Type: 8-K
Importance Score:
7
KVUE
Feb 12, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
7
KVUE
Jan 29, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
KVUE
Jan 27, 2026, 5:21 PM EST
Filing Type: 425
Importance Score:
9
KVUE
Jan 16, 2026, 5:29 PM EST
Filing Type: 425
Importance Score:
8
KVUE
Jan 16, 2026, 5:28 PM EST
Filing Type: 425
Importance Score:
8
KVUE
Jan 16, 2026, 5:27 PM EST
Filing Type: 8-K
Importance Score:
7
KVUE
Jan 16, 2026, 5:23 PM EST
Filing Type: 425
Importance Score:
7
KVUE
Jan 13, 2026, 5:20 PM EST
Filing Type: 425
Importance Score:
9
KVUE
Jan 13, 2026, 5:00 PM EST
Filing Type: 425
Importance Score:
10
KVUE
Jan 08, 2026, 5:05 PM EST
Filing Type: 425
Importance Score:
9
KVUE
Jan 08, 2026, 4:30 PM EST
Filing Type: 425
Importance Score:
9
KVUE
Jan 07, 2026, 5:15 PM EST
Filing Type: 425
Importance Score:
8